Discover
The Mood Wellness Ketamine, Spravato, and TMS Center
The Mood Wellness Ketamine, Spravato, and TMS Center
Author: Brad Masters
Subscribed: 2Played: 64Subscribe
Share
© 2025 Brad Masters
Description
Discover hope and healing with The Mood Wellness Podcast, where we explore mental health solutions like ketamine therapy, Spravato therapy, TMS, and more. Join experts as they discuss breakthroughs in treating depression, anxiety, PTSD, and chronic pain, offering insights to reclaim your well-being.
3 Episodes
Reverse
As a key figure at The Mood Center, Brad Masters has dedicated his career to helping those with challenging mental health and chronic pain issues.
He focuses on treatment-resistant conditions like depression, anxiety, trauma, and chronic pain. His approach brings new hope to those who have not found relief with traditional solutions.
Brad is passionate about patient experience at every step of the care process. He values the power of a supportive team, advanced therapies, and education for his clients.
Through his work, he aims to speed up positive changes in patients’ lives. He now leads The Mood Center’s two Maryland locations: Annapolis and Columbia.
The Mood Center: Innovative Interventional Psychiatry
The Mood Center stands out for its commitment to interventional psychiatry. The team focuses on people who have not found relief with standard medications.
Common conditions treated include depression, anxiety, PTSD, and sometimes chronic pain. Many patients have tried multiple medications or prefer to avoid them altogether.
The center prioritizes cutting-edge treatments rather than sticking with older medications. Patients benefit from therapies such as ketamine, Spravato, and soon, TMS.
A comprehensive approach ensures each client feels understood and guided. The Mood Center’s staff works hard to make every person comfortable from the very first contact.
Next-Generation Treatments: Ketamine and Spravato
The Mood Center is at the forefront of new therapies. Ketamine and Spravato are leading options offered for those needing something different.
Ketamine works differently than most traditional medications. By acting on glutamate and supporting neuroplasticity, it helps create new pathways in the brain.
Spravato, the nasal spray version of esketamine, is FDA-cleared for treatment-resistant depression. It has recently been approved as a standalone option.
Both treatments rapidly help patients who have not responded to SSRIs or other standard drugs. The center uses these new solutions to bring relief even when other strategies fail.
The Patient Experience at The Mood Center
A focus on patient comfort shapes every aspect of The Mood Center. From the first phone call, staff offer support and education.
New patients receive a thorough assessment to confirm the best fit for treatment. The care team aims to empower each person with information and choice.
Ketamine sessions include extras for comfort, such as heated reclining chairs, soft lighting, and aromatherapy. Journals are provided to help patients set intentions and track changes.
Noise-canceling headphones, eye masks, and customizable room features create a personalized environment. Medical monitoring is standard in every private treatment room.
These thoughtful details help ease anxiety for those new to advanced psychiatric treatments. Support continues throughout the entire process, building trust and confidence.
Transformative Results: Success Stories and Outcomes
Patients describe a variety of positive changes after receiving care. Some experience rapid improvement, while others notice gradual shifts that add up.
Patients commonly report lower stress, calmer reactions, and moments of new insight. Many have felt able to reduce or stop other psychiatric drugs after beginning ketamine.
The center has witnessed remarkable stories, such as veterans regaining mobility and individuals overcoming severe OCD symptoms. Small improvements, like feeling less reactive, are also celebrated.
Gratitude, regular journaling, and recognition of every step forward are encouraged. Feedback from clients shows satisfaction with the approach and results.
The Mood Center sees its mission as supporting each individual transformation, no matter how small. The journey often includes both therapy and advanced medication.
Addressing a Range of Conditions
The Mood Center treats more than depression. Patients seek help for OCD, PTSD, chronic pain, and even challenges related to substance dependence.
People with obsessive-compulsive tendencies have experienced healing, regaining comfort and confidence in their lives. Trauma clients, including veterans with PTSD, have reported breakthroughs.
Chronic pain conditions, such as those affecting mobility, are managed with promising outcomes. Some clients have even been able to walk again after years of struggle.
Support extends to those tapering off benzodiazepines or opiates, where ketamine can ease difficult transitions. Alcohol use disorders have also been addressed, working alongside therapy and recovery programs.
Each condition is met with compassion and individualized attention. The goal is to open doors wherever standard methods have fallen short.
Looking Ahead: Expanding Access and Hope
The Mood Center continues to grow, with new locations and expanded clinic hours. Annapolis and Columbia, Maryland, both offer advanced treatment sessions for the community.
The latest developments in FDA approval now allow some treatments as standalone options, improving access for more people. The team looks ahead to a future with even fewer barriers.
Patient education and involvement are central to every phase of care. The clinic believes everyone should understand their options and feel empowered in their journey.
As innovations continue, The Mood Center remains committed to a caring, comprehensive experience. Its leaders believe that advanced therapies will soon become the norm for those with challenging mental health concerns.
The Mood Center is shaping a more hopeful future. The mission is simple: offer safety, support, and the most effective tools available to help each person thrive.
Subscribe to The Mood Wellness Ketamine, Spravato, and TMS Center on Soundwise
Understanding Ketamine's Role in Migraine Management
Ketamine has emerged as a potential option for treating migraines in recent years. This medication was originally used as an anesthetic in medical settings.
Many patients with treatment-resistant migraines are now exploring ketamine as an alternative therapy. The growing interest in ketamine treatments has prompted further research into its effectiveness for migraine relief.
Medical professionals administer ketamine in controlled environments to ensure patient safety. The medication works by blocking specific receptors in the brain called NMDA receptors.
These receptors play a significant role in pain transmission and central sensitization. Ketamine's ability to disrupt these pain pathways makes it potentially valuable for migraine treatment.
The dosage used for migraine treatment is typically lower than what's used for anesthesia. This lower dosage helps minimize unwanted reactions while maintaining therapeutic benefits.
How Ketamine Infusions Work for Migraine Relief
Ketamine infusions are typically administered intravenously in a clinical setting. The procedure usually takes between 40 minutes to an hour depending on the protocol.
During treatment, patients remain awake but may experience mild dissociative effects. These effects typically subside shortly after the infusion ends.
Most treatment plans include a series of infusions over several days or weeks. In addition, maintenance treatments may be recommended to sustain the benefits over time.
The effects of ketamine can sometimes be felt immediately following treatment. However, the full benefits may develop gradually over subsequent days.
Patients often report a reduction in both migraine frequency and intensity following ketamine therapy. As a result, many experience improved quality of life and reduced disability.
Benefits of Ketamine for Chronic Migraine Patients
Ketamine offers rapid relief for some patients who haven't responded to conventional treatments. Furthermore, this quick action can be crucial for those suffering from debilitating migraine attacks.
The medication may help break the cycle of chronic migraines in some individuals. The interruption of pain pathways can potentially reset the brain's pain processing mechanisms.
Some patients report longer periods between migraine episodes following ketamine treatment. These extended migraine-free intervals allow for better functioning and less medication use.
Ketamine treatments might reduce the need for other migraine medications in some cases. Consequently, this reduction can limit exposure to medications that cause rebound headaches with frequent use.
The benefits of ketamine may extend beyond pain relief for certain patients. Many report improvements in associated symptoms like nausea, light sensitivity, and sound sensitivity.
Patient Selection for Ketamine Migraine Therapy
Not all migraine sufferers are ideal candidates for ketamine treatment. Patients who have failed multiple conventional treatments are typically considered first.
A thorough medical evaluation is essential before beginning ketamine therapy. This assessment helps identify any contraindications or risk factors.
Patients with certain conditions may not be suitable for ketamine treatment. For example, uncontrolled high blood pressure or certain cardiac issues may exclude some individuals.
Mental health history is another important consideration before starting treatment. Moreover, the treating physician will typically review all current medications for possible interactions.
The financial aspect also factors into patient selection for these treatments. Insurance coverage for ketamine infusions varies widely, and treatments can be costly.
The Ketamine Treatment Experience
Most ketamine infusions take place in specialized clinics or hospital settings. These environments are equipped with monitoring equipment and medical personnel.
Patients typically sit in a comfortable chair or recline during the infusion process. The room is usually kept quiet with minimal stimulation.
Vital signs are monitored throughout the treatment to ensure safety. In addition, medical staff remain available to address any concerns during the procedure.
Some patients report unusual sensations during the infusion, such as feeling disconnected or experiencing altered perceptions. These temporary effects are considered normal parts of the treatment.
After the infusion, patients remain in the facility for observation before going home. Transportation arrangements are necessary as patients cannot drive after receiving ketamine.
Comparing Ketamine to Traditional Migraine Treatments
Traditional migraine treatments often take weeks or months to show effectiveness. In contrast, ketamine may provide relief much more quickly for some patients.
Conventional preventive medications typically require daily dosing regardless of headache status. Ketamine, however, is administered periodically in a clinical setting without daily medication.
Many standard migraine medications carry risks with long-term use. On the other hand, ketamine's periodic administration may limit cumulative exposure risks.
Traditional treatments often target specific aspects of migraine pathophysiology. Ketamine works through different mechanisms, potentially offering benefits when other approaches fail.
The side effect profiles differ significantly between ketamine and conventional treatments. As a result, some patients who cannot tolerate standard medications may find ketamine more manageable.
Future Developments in Ketamine Migraine Treatment
Research into ketamine for migraines continues to evolve with new delivery methods under investigation. Nasal sprays and other non-intravenous options may eventually provide more accessible treatments.
Combination therapies using ketamine alongside other medications are being explored. These approaches may enhance effectiveness while reducing required ketamine doses.
Home-based ketamine treatments are under consideration for certain patient populations. However, safety concerns and monitoring requirements present significant challenges to this model.
Longer-term studies are examining the durability of ketamine's benefits for migraine patients. These studies will help determine optimal treatment intervals and maintenance protocols.
Cost-effectiveness research may influence future insurance coverage decisions. Consequently, this could make treatments more accessible to a broader range of patients in the coming years.
Subscribe to The Mood Wellness Ketamine, Spravato, and TMS Center on Soundwise
Welcome to The Mood Center Podcast, where we explore cutting-edge approaches to mental health and wellness, brought to you by The Mood Center in Columbia, Maryland. This podcast delves into the innovative treatments transforming lives every day, including ketamine infusions, Spravato therapy, Transcranial Magnetic Stimulation (TMS), and personalized integration therapy.
We tackle the toughest mental health challenges, including OCD, PTSD, treatment-resistant depression, anxiety, addiction, chronic pain, migraines, and even chronic Lyme disease. Join us for deep conversations with medical professionals, therapists, patients, and industry experts as we uncover how these therapies work and the stories of hope and healing behind them.
Whether you're a healthcare professional, someone seeking answers for yourself or a loved one, or simply curious about the future of mental health treatment, this is the podcast for you. Together, let's break the stigma and explore new paths to better mental health.
Visit us at https://themoodcenter.com
Subscribe to The Mood Wellness Ketamine, Spravato, and TMS Center on Soundwise




